论文部分内容阅读
由于多种原因,肝癌术后复发率长期以来居高不下,为了降低术后复发率,许多学者作了大量的研究工作,我院自91年起采用预防性肝动脉灌注化疗(TAI)作为肝癌术后的常规疗法,取得满意效果. 1.资料与方法 1.1临床资料肝癌根治术后患者192例,其中预防组104例,接受TAI,术前肿块<3cm者12例,3-8cm者56例,>8cm者36例;对照组88例,未接受TAI,术前肿块<3cm者15例,3-8cm者44例,>8cm者29例.随访1-7.5年.
For a variety of reasons, the recurrence rate of liver cancer has remained high for a long period of time. In order to reduce the recurrence rate after surgery, many scholars have done a lot of research work, our hospital has adopted preventive hepatic artery infusion chemotherapy (TAI) as a liver cancer since 1991. After the routine treatment, to achieve satisfactory results. 1. Materials and Methods 1.1 Clinical data 192 cases of patients with hepatic cancer after radical surgery, including 104 cases of prevention group, receiving TAI, preoperative tumor mass <3cm in 12 cases, 3-8cm in 56 cases. , >8cm in 36 cases; control group in 88 cases, did not receive TAI, preoperative tumor <3cm in 15 cases, 3-8cm in 44 cases,> 8cm in 29 cases. Follow-up 1-7.5 years.